Remove 2027 Remove Packaging Remove Testimonials
article thumbnail

Analysis Life Sciences Thank You Everything the FDA is planning to do in Q3 2023

Agency IQ

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. But despite the law’s age, it is not yet fully operational. The final rule will amend the administrative destruction provisions in 21 CFR 1.94

FDA 40